NZ609666A - Methods and compositions for diagnosis and prognosis of renal injury and renal failure - Google Patents

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Info

Publication number
NZ609666A
NZ609666A NZ609666A NZ60966610A NZ609666A NZ 609666 A NZ609666 A NZ 609666A NZ 609666 A NZ609666 A NZ 609666A NZ 60966610 A NZ60966610 A NZ 60966610A NZ 609666 A NZ609666 A NZ 609666A
Authority
NZ
New Zealand
Prior art keywords
receptor
endothelial protein
soluble endothelial
measured concentration
subject
Prior art date
Application number
NZ609666A
Inventor
Kevin Nakamura
Jeff Gray
Joseph Anderberg
Paul Mcpherson
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Priority to NZ630621A priority Critical patent/NZ630621A/en
Publication of NZ609666A publication Critical patent/NZ609666A/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Disclosed is an ex vivo method for evaluating renal status in a subject, comprising: performing one or more assays configured to detect Soluble endothelial protein C receptor in a body fluid sample obtained previously from the subject to provide one or more assay results, wherein an assay configured to detect Soluble endothelial protein C receptor comprises contacting the body fluid sample with one or more antibodies or antibody fragments that bind to Soluble endothelial protein C receptor or part thereof, to thereby form a complex, and determining a measured concentration of Soluble endothelial protein C receptor in the body fluid sample based on an amount of the complex formed; and correlating the assay result(s) to one or more of risk stratification, staging, prognosis, classifying and monitoring of the renal status of the subject, wherein said correlating comprises comparing the measured concentration of Soluble endothelial protein C receptor to a threshold concentration of Soluble endothelial protein C receptor, and assigning a likelihood of a future event occurring or determining that an event has occurred when the measured concentration varies from the threshold, or assigning a likelihood of a future event not occurring or determining that an event has not occurred when the measured concentration does not vary from the threshold.
NZ609666A 2009-02-06 2010-02-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure NZ609666A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ630621A NZ630621A (en) 2009-02-06 2010-02-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US15037209P 2009-02-06 2009-02-06
US15039309P 2009-02-06 2009-02-06
US15037409P 2009-02-06 2009-02-06
US16240209P 2009-03-23 2009-03-23
US16239609P 2009-03-23 2009-03-23
US16633309P 2009-04-03 2009-04-03
NZ59477010 2010-02-05

Publications (1)

Publication Number Publication Date
NZ609666A true NZ609666A (en) 2014-11-28

Family

ID=52464932

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ609666A NZ609666A (en) 2009-02-06 2010-02-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Country Status (1)

Country Link
NZ (1) NZ609666A (en)

Similar Documents

Publication Publication Date Title
NZ604873A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ625423A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ601575A (en) Methods and compositions for diagnosis and prognosis of renal injury and failure
NZ607703A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ701807A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ628085A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ610356A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ630621A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ700695A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ592365A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ593514A (en) p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer
NZ598034A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ624614A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ598712A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ608384A (en) Biomarkers of renal injury
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
BRPI0707645B8 (en) in vitro methods for detecting cancer in an individual and for evaluating the prognosis of an individual having, or suspected of having, ovarian cancer
NO20076656L (en) Improved immunoassay methods
NZ606124A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
JP2012073260A5 (en)
NZ612673A (en) Methods and composition for diagnosis and prognosis of renal injury and renal failure

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 05 FEB 2017 BY FB RICE

Effective date: 20150306

LAPS Patent lapsed